AKER CHRISTOPHER RAY (Sr. VP & General Counsel) sold 35.2% of their position (5.47K shares) of REGULUS THERAPEUTICS INC. on the open market
Open‑market sale worth $6.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/18/2024ACC: 0001209191-24-001874
Officer· Sr. VP & General Counsel
Since Jan 2019
-5.47K
Net shares
Net seller
$6.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.47K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.47K
Price / share
$1.19
Trade value
$6.51K
% of position
35.2%
1/18/2024
15.52K→10.06K
Total
Net shares
−5.47K
Net value
-$6.51K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/18/2024 | S · Sale | −5.47K | $1.19 | $6.51K | 35.2% | 15.52K | 10.06K |
| Total | −5.47K | -$6.51K | ||||||
Derivative Transactions0
No derivative transactions reported